Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464542 · ClinicalTrials.gov registry record · Phase 4
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
A Phase 4 study of Bacterial Vaginosis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT00464542: Completed Phase 4 study of Bacterial Vaginosis, sponsored by University of Pittsburgh.
NCT00464542 is a Phase 4 study of Bacterial Vaginosis that has completed, run by University of Pittsburgh. The registered enrollment target is 12 participants, below the 337-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00464542, a Phase 4 study of Bacterial Vaginosis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
This investigation assessed the effects of asymptomatic BV on daily genital tract shedding of HSV-2 by determining shedding frequency before and after treatment of asymptomatic BV.
Primary Outcome
Bacterial vaginosis, defined as any vaginal smear with a Nugent score of 7-10 during the 30 day period following cessation of metronidazole therapy.
Conditions Studied
Interventions
- DRUG Metronidazole
Study Locations (2)
Pennsylvania
- University of Pittsburgh - Pittsburgh
- University of Pittsburgh, Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
What the finished NCT00464542 record still lists
NCT00464542 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 337-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which Metronidazole is the first listed.
NCT00464542 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00464542 about?
NCT00464542 is a clinical study titled "Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study". This investigation assessed the effects of asymptomatic BV on daily genital tract shedding of HSV-2 by determining shedding frequency before and after treatment of asymptomatic BV.
What is the current status of trial NCT00464542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-12. Estimated completion is 2010-03.
What conditions does trial NCT00464542 study?
This clinical trial studies the following conditions: Bacterial Vaginosis.
What interventions are being tested in trial NCT00464542?
The interventions under investigation include: Metronidazole (DRUG).
Who is sponsoring clinical trial NCT00464542?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00464542 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00464542's enrollment target sits among peer trials
12 14th of 15 higher than 2 of 15 other Bacterial Vaginosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Vaginosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
-
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
COMPLETED · Phase 4
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia